Use of subcutaneous fat determination to determine visceral fat and cardiovascular risk profile of patients and subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032545

Enrollment

Registered

2023-08-24

Start date

2017-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type 2 diabetes mellitus

Interventions

Group 1: Methological Study -Development and evaluation of a subcutaneous mapping procedure -reliability of mapping procedure -verification of intraobserver reliability -Validation of the subcutaneous

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient Cohort: -BMI over 25 Control group -BMI under 25

Exclusion criteria

Exclusion criteria: For MRI subjects: Metal implant and defibrillators/pacemakers and weight = 100kg. - pregnancy - high probability of insufficient compliance - simultaneous participation in other examinations - BMI > 40 - Pregnancy - Chronic infectious diseases - Orthopedic and internal acute diseases - Diseases with exercise-induced risks (e.g. progressive heart failure, exercise-induced hypertension)

Design outcomes

Primary

Measure	Time frame
Quantitative determination of subcutaneous fat: mapping and algorithm development.	—

Secondary

Measure	Time frame
Reliability determination of the mapping procedure: inter- and intraobserver reliability	—

Countries

Germany

Contacts

Public ContactMartin Busse

Sportmedizinsiche Hochschulambulanz Leipzig

gerlach@uni-leipzig.de03419731660

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026